Breaking News Instant updates and real-time market news.

SNAP

Snap

$9.20

0.01 (0.11%)

, DVA

DaVita

$70.43

2.83 (4.19%)

10:27
09/13/18
09/13
10:27
09/13/18
10:27

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Snap (SNAP) upgraded to Hold from Sell at Pivotal Research with analyst Brian Wieser saying risks are still present, especially in the near-term, but current trading levels balance those risks with the company' long-term potential. 2. DaVita (DVA) upgraded to Neutral from Underweight at JPMorgan with analyst Gary Taylor saying he now believes is it much more likely that California Governor Brown will veto the recently passed SB1156, which he notes would curtail the financial arbitrage that dialysis providers enjoy from charitable premium assistance. 3. Intel (INTC) upgraded to Market Perform from Underperform at Northland with analyst Auguste Richard saying the stock has corrected 23% from its 52-week high and is down 20% since mid-June. 4. Magna (MGA) upgraded to Outperformer from Neutral at CIBC. 5. Flowserve (FLS) upgraded to Buy from Neutral at Northcoast. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

SNAP

Snap

$9.20

0.01 (0.11%)

DVA

DaVita

$70.43

2.83 (4.19%)

INTC

Intel

$45.54

0.61 (1.36%)

MGA

Magna

$53.80

1.36 (2.59%)

FLS

Flowserve

$54.60

1.33 (2.50%)

  • 18

    Sep

SNAP Snap
$9.20

0.01 (0.11%)

09/12/18
09/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Micron (MU) downgraded to Neutral from Buy at Goldman Sachs with analyst Mark Delaney seeing weaker fundamentals for DRAM and NAND in calendar Q4 and the first half of 2019. 2. NXP Semiconductors (NXPI) downgraded to Sell from Hold at Stifel wit hanalyst Tore Svanberg arguing that multiple recent industry data points seem to suggest the analog and mixed-signal semiconductor markets are peaking. 3. Snap (SNAP) downgraded to Sell from Neutral at BTIG with analyst Richard Greenfield saying his previous assumption that "communications apps were sticky and would protect engagement" was incorrect. 4. Acuity Brands (AYI) downgraded to Sell from Neutral at Goldman Sachs with analyst Brian Lee seeing three key issues emanating around margin risk: mix, costs, and pricing power. 5. CenterState Bank (CSFL) downgraded to Hold from Buy at Sandler O'Neill with analyst Stephen Scouten saying further near-term upside "appears minimal" from current valuation levels. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/18
PIVT
09/13/18
UPGRADE
Target $9
PIVT
Hold
Pivotal Research upgrades Snap to Hold following recent selloff
Pivotal Research analyst Brian Wieser upgraded Snap to Hold from Sell with an unchanged price target of $9. The stock closed yesterday down 7%, or 69c, to $9.20. Risks are still present, especially in the near-term, but current trading levels balance those risks with the company' long-term potential, Wieser tells investors in a research note. Risks include "aggressive competition from much larger companies," a core user base that is "not growing by much and is only relatively elusive," and a "sub-optimal corporate structure," according to the analyst. However, while Wieser does not expect Snap to be acquired "any time soon," he believes such an event can't be ruled out. "This at least should help to provide a floor on the company's underlying value, at least so long as usage trends don't crater," he contends.
09/12/18
PIVT
09/12/18
UPGRADE
Target $9
PIVT
Hold
Snap upgraded to Hold from Sell at Pivotal Research
Pivotal Research analyst Brian Wieser upgraded Snap to Hold from Sell with a price target of $9.
09/12/18
09/12/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN CUTS MICRON TO NEUTRAL: Goldman Sachs analyst Mark Delaney downgraded Micron Technology (MU) to Neutral from Buy and lowered his price target for the shares to $50 from $68. The analyst, who is not making a call on the upcoming fiscal Q4 results on September 20, sees weaker fundamentals for DRAM and NAND in calendar Q4 and the first half of 2019. Delaney expects Micron's gross margin to decline sequentially from Q4 of 2018 through mid-2019, and he notes that the stock is historically well correlated with the company's gross margin. His view of margin declines is due to lower memory average selling prices, both from more "challenging" DRAM conditions and also NAND oversupply. Micron is down 5.8% in late morning trading. GOLDMAN CUTS LAM RESEARCH TO NEUTRAL: Goldman Sachs analyst Toshiya Hari downgraded Lam Research (LRCX) to Neutral and lowered his price target for the shares to $180 from $224. The analyst also lowered his coverage view on the Semiconductor Capital Equipment space to Neutral from Attractive. Hari reduced his 2018/2019 memory capex expectations following "early signs of excess supply" in DRAM combined with further weakness in NAND pricing. STIFEL CUTS NXP SEMI, OTHER SEMI COS: Stifel analyst Tore Svanberg downgraded NXP Semiconductors (NXPI) to Sell from Hold, arguing that multiple recent industry data points seem to suggest the analog and mixed-signal semiconductor markets are peaking. He is particularly concerned, given the peaking industry condition, that rising interest rates raise the risk for debt-heavy firms, he added. Svanberg cut his price target on NXP shares to $84 from $99. Svanberg also downgraded Macom (MTSI) to Sell, and Power Integrations (POWI) and Maxim Integrated (MXIM) to Hold. ANALYSTS NEGATIVE ON SNAP: BTIG analyst Richard Greenfield downgraded Snap (SNAP) to Sell from Neutral with a price target of $5, saying his previous assumption that "communications apps were sticky and would protect engagement" was incorrect. The analyst notes that while he waited for "management to figure out monetization", the stock has lost over half of its value. Greenfield believes that the pain is likely not over, stating that he is now "tired" of the company's excuses for missing numbers and adding that the anticipated product innovation ability of CEO Spiegel has been disappointing. Additionally, Citi analyst Mark May lowered his price target for Snap to $8 after removing his takeover premium assumption. The analyst had assumed a 50% probability of a takeout at a 35% premium to his fundamental value of $8 per share. However, he now sees less likelihood of a near-term takeover due to Snap's recent operational challenges. The analyst kept a Sell rating on the shares.
DVA DaVita
$70.43

2.83 (4.19%)

09/13/18
JPMS
09/13/18
UPGRADE
Target $68
JPMS
Neutral
DaVita upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Gary Taylor upgraded DaVita to Neutral with a $68 price target.
09/13/18
JPMS
09/13/18
UPGRADE
Target $68
JPMS
Neutral
JPMorgan upgrades DaVita to Neutral on better chance of SB1156 veto
JPMorgan analyst Gary Taylor upgraded DaVita to Neutral from Underweight with an unchanged price target of $68. The analyst now believes is it much more likely that California Governor Brown will veto the recently passed SB1156, which he notes would curtail the financial arbitrage that dialysis providers enjoy from charitable premium assistance. With shares of DaVita down nearly 10% since the bill's passage, the analyst sees "better prospects for the stock to recover that ground" in the near-term. As such, he views the company's risk/reward as more balanced at current share levels. However, Taylor retains his longer-term concern regarding the charitable premium assistance "cat & mouse" game between employers/insurers and dialysis providers.
08/30/18
BARD
08/30/18
NO CHANGE
Target $90
BARD
Outperform
DaVita risk from California Senate bill 'seems manageable,' says Baird
The California Assembly last night passed Senate Bill 1156, which limits charitable premium assistance, Baird analyst Matthew Gillmor tells investors in a research note. The analyst estimates DaVita's gross earnings risk at 8%. JPMorgan this morning estimated that risk at 10%. Shares of DaVita are down 7%, or $5.10, to $67.93 in morning trading. Gillmor says that while DaVita shares arguably price in "significant risk" associated with Service Employees International Union's ballot efforts, he had been hopeful the industry would be successful in combating these initiatives. His conviction level now "moves somewhat lower," but he feels DaVita's risk associated with SB 1156 "seems manageable." The analyst keeps an Outperform rating on the stock with a $90 price target.
08/30/18
JPMS
08/30/18
NO CHANGE
Target $68
JPMS
Overweight
California bill puts 10% of DaVita's earnings at risk, says JPMorgan
The California Assembly yesterday passed an amended version of Senate Bill 1156, which, among other things, requires that entities providing charitable premium assistance to identify and disclose to the health plan the details of each person assisted, JPMorgan analyst Gary Taylor tells investors in a research note. The analyst expects the Californian Senate to approve the amended version via a concurrence vote today, sending the bill to Governor Brown for approval or veto. The bill could "impair" approximately half of DaVita's California earnings, or approximately 10% of its total corporate earnings, Taylor estimates. He also sees risk that other states could adopt similar legislation. The analyst keeps an Underweight rating on DaVita with a $68 price target.
INTC Intel
$45.54

0.61 (1.36%)

09/13/18
DBAB
09/13/18
NO CHANGE
Target $23
DBAB
Hold
Deutsche Bank boosts AMD target, but says 'goodness' fully priced in
Deutsche Bank analyst Ross Seymore raised his price target for AMD (AMD) to $23 from $14 after hosting the company's CFO Devinder Kumar at his firm's 2018 Tech Conference. The chipmaker closed yesterday up 7%, or $2.11, to $32.21. The analyst found Kumar's comments to be positive, noting the company reiterated its product-specific growth drivers and share gain plans within the server, graphics, and PC markets. Seymore continues to be impressed by AMD's execution with the company "capitalizing not only on its strong new product traction but also on competitor missteps." However, even with his raised 2020 estimates, the analyst believes "the goodness at AMD is already fully reflected in its share price." The stock's current valuation is elevated at 34 times consensus 2020 earnings estimates, Seymore tells investors in a research note. Further, he believes upside in earnings to the most bullish estimates likely ignores the potential for competitive responses from Intel (INTC) and Nvidia (NVDA). Seymore keeps a Hold rating on AMD.
09/10/18
MZHO
09/10/18
NO CHANGE
Target $27
MZHO
Mizuho sees strong second half for ON Semiconductor
Mizuho analyst Vijay Rakesh reiterates a Buy rating on ON Semiconductor (ON) with a $27 price target after hosting investor meetings with management. Channel inventory remains at the low end and the company's auto catalysts include $200 per car of electric vehicle content shipping to China manufacturers, Rakesh tells investors in a research note. Further, he believes ON's 2019 server content likely grows 50% to $45 on next generation Intel (INTC) servers. The analyst sees a "strong" strong half of the year for the company.
09/12/18
SBSH
09/12/18
NO CHANGE
SBSH
Neutral
Citi sees July PC shipment data as positive for Intel
July PC shipments increased 10% month-over-month, below normal seasonality of up 14% but in line with Citi Taiwan hardware analyst Carrie Liu's expectation, Citi analyst Christopher Danely tells investors in a research note. The analyst believes these data points are positive for both Intel and the sector given that the PC end market represents roughly 66% of Intel's profits and 31% of overall semi sector sales. He keeps a Neutral rating on Intel shares.
09/13/18
NORL
09/13/18
UPGRADE
NORL
Market Perform
Intel upgraded to Market Perform from Underperform at Northland
Northland analyst Auguste Richard upgraded Intel to Market Perform from Underperform, noting that the stock has corrected 23% from its 52-week high and is down 20% since mid-June. While he does not think the correction has been overdone, Richard now sees the risk/reward for Intel shares as more balanced, he tells investors.
MGA Magna
$53.80

1.36 (2.59%)

09/13/18
CIBC
09/13/18
UPGRADE
CIBC
Outperformer
Magna upgraded to Outperformer from Neutral at CIBC
05/14/18
EVER
05/14/18
INITIATION
EVER
Outperform
Magna initiated with an Outperform at Evercore ISI
Evercore ISI analyst Chris McNally initiated Magna with an Outperform and $80 price target.
08/28/18
WELS
08/28/18
NO CHANGE
WELS
Tentative U.S./Mexico trade deal a starting point for auto stock recovery, says Wells Fargo
Wells Fargo analyst Richard Kwas believes the U.S./Mexico tentative trade deal is a positive for the automotive space in the interim. In his view, part of the recent underperformance has come from trade uncertainty. NA centric supplier names like Magna (MGA) and Tower International (TOWR) could be the biggest beneficiaries. MGA does have material revenue exposure to Canada and therefore the absence of Canada in a final agreement would create some level of complication for the company relative to the rest of supplier group, he notes. Kwas believes the decision to limit non Mexico/U.S. content to 25% of vehicle value coupled with the 40%-45% minimum threshold for $16/hour manufacturing jobs should stabilize or increase U.S. share of vehicle production.
05/14/18
EVER
05/14/18
INITIATION
Target $80
EVER
Outperform
Magna initiated with an Outperform at Evercore ISI
As noted earlier, Evercore analyst Chris McNalty initiated Magna with an Outperform rating and a price target of $80. The analyst says the company is "hiding in plain sight" the investment opportunity to own a "best-in-class, diversified, mega supplier" with "strong" visibility to transform its business from legacy toward growth over the course of the next cycle. McNalty adds that his Sum-of-Parts valuation model is also "compelling" while anticipating an inflection in margins and accelerating growth in FY19.
FLS Flowserve
$54.60

1.33 (2.50%)

09/13/18
NRCS
09/13/18
UPGRADE
NRCS
Buy
Flowserve upgraded to Buy from Neutral at Northcoast
08/13/18
STFL
08/13/18
NO CHANGE
Target $47
STFL
Hold
Flowserve price target raised to $47 from $43 at Stifel
Stifel analyst Nathan Jones maintained a Hold rating on Flowserve but raised his price target for shares to $47 from $43 following a "solid" operational quarter and improving end markets, but tells investors that shares are still trading at "expensive" levels. Jones says the company believes the cycle has turned, and he agrees, evidenced by greater than $1B of bookings for the first time in three years, made up of mostly smaller base orders with management reporting a pipeline that looks robust.
08/14/18
COWN
08/14/18
NO CHANGE
Target $58
COWN
Outperform
Flowserve price target raised to $58 from $50 at Cowen
Cowen analyst Joseph Giordano raised his price target on Flowserve to $58 from $50 following Q2 results. The analyst believes the quarter marked the beginning of an operating and positioning inflection with potential momentum building toward the Investor Day in December. Giordano reiterated his Outperform rating on Flowserve shares.
08/20/18
MSCO
08/20/18
INITIATION
Target $50
MSCO
Equal Weight
Flowserve initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Joshua Pokrzywinski initiated Flowserve with an Equal Weight rating and a price target of $50.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,760.99

-27.64 (-1.55%)

06:29
10/16/18
10/16
06:29
10/16/18
06:29
Periodicals
Amazon may launch robots with new-generation tech in 2019, DigiTimes reports »

Amazon is likely to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 25

    Oct

ESPR

Esperion

$44.94

-1.21 (-2.62%)

, MRK

Merck

$69.46

-0.31 (-0.44%)

06:29
10/16/18
10/16
06:29
10/16/18
06:29
Initiation
Esperion, Merck initiated  »

Esperion initiated with a…

ESPR

Esperion

$44.94

-1.21 (-2.62%)

MRK

Merck

$69.46

-0.31 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

AMZN

Amazon.com

$1,760.99

-27.64 (-1.55%)

06:22
10/16/18
10/16
06:22
10/16/18
06:22
Periodicals
Amazon CEO calls current internet a 'confirmation bias machine', BI reports »

Amazon CEO Jeff Bezos…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 25

    Oct

TSQ

Townsquare Media

$7.40

0.09 (1.23%)

06:21
10/16/18
10/16
06:21
10/16/18
06:21
Conference/Events
Townsquare Media management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

TLRY

Tilray

$165.71

17.56 (11.85%)

06:21
10/16/18
10/16
06:21
10/16/18
06:21
Initiation
Tilray initiated  »

Tilray initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRO

Spero Therapeutics

$9.83

0.23 (2.40%)

06:18
10/16/18
10/16
06:18
10/16/18
06:18
Downgrade
Spero Therapeutics rating change  »

Spero Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$115.06

-1.34 (-1.15%)

, PYPL

PayPal

$77.22

-1.8 (-2.28%)

06:17
10/16/18
10/16
06:17
10/16/18
06:17
Recommendations
Ferrari, PayPal, ADP, NetApp analyst commentary  »

Ferrari, PayPal added to…

RACE

Ferrari

$115.06

-1.34 (-1.15%)

PYPL

PayPal

$77.22

-1.8 (-2.28%)

ADP

ADP

$140.27

-0.44 (-0.31%)

NTAP

NetApp

$75.35

-1.61 (-2.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 31

    Oct

  • 13

    Nov

  • 26

    Nov

MBWM

Mercantile Bank

$32.28

0.59 (1.86%)

06:17
10/16/18
10/16
06:17
10/16/18
06:17
Hot Stocks
Mercantile Bank announces 75c special cash dividend »

Mercantile Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

HF

HFF Inc.

$36.99

0.6 (1.65%)

06:17
10/16/18
10/16
06:17
10/16/18
06:17
Hot Stocks
HFF sells Sheraton Denver Downtown Hotel »

Holliday Fenoglio Fowler…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$73.00

0.51 (0.70%)

, SHLD

Sears

$0.31

-0.0901 (-22.52%)

06:16
10/16/18
10/16
06:16
10/16/18
06:16
Recommendations
Best Buy, Sears analyst commentary  »

Best Buy to be major…

BBY

Best Buy

$73.00

0.51 (0.70%)

SHLD

Sears

$0.31

-0.0901 (-22.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$0.00

(0.00%)

, BMWYY

BMW

$0.00

(0.00%)

06:16
10/16/18
10/16
06:16
10/16/18
06:16
Periodicals
Daimler, BMW offer concessions to ease EU antitrust concerns, Reuters reports »

Germany luxury automakers…

DDAIF

Daimler AG

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPR

Tapestry

$43.09

-0.72 (-1.64%)

06:16
10/16/18
10/16
06:16
10/16/18
06:16
Upgrade
Tapestry rating change  »

Tapestry upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SYMC

Symantec

$19.78

0.19 (0.97%)

06:15
10/16/18
10/16
06:15
10/16/18
06:15
Upgrade
Symantec rating change  »

Symantec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Dec

BLK

BlackRock

$427.40

-0.18 (-0.04%)

06:14
10/16/18
10/16
06:14
10/16/18
06:14
Hot Stocks
BlackRock CEO: Q3 results highlight resilience of our differentiated platform »

Laurence Fink, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

TWLO

Twilio

$76.26

1.27 (1.69%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

06:14
10/16/18
10/16
06:14
10/16/18
06:14
Recommendations
Twilio, SendGrid analyst commentary  »

Twilio should be bought…

TWLO

Twilio

$76.26

1.27 (1.69%)

SEND

SendGrid

$30.94

0.04 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

MBWM

Mercantile Bank

$32.28

0.59 (1.86%)

06:13
10/16/18
10/16
06:13
10/16/18
06:13
Earnings
Mercantile Bank reports Q3 EPS 61c, consensus 61c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

BLK

BlackRock

$427.40

-0.18 (-0.04%)

06:12
10/16/18
10/16
06:12
10/16/18
06:12
Hot Stocks
BlackRock reports $11B of quarterly long-term net inflows in Q3 »

Led by iShares, active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

BLK

BlackRock

$427.40

-0.18 (-0.04%)

06:11
10/16/18
10/16
06:11
10/16/18
06:11
Hot Stocks
BlackRock reports Q3 AUM $6.4T, up 8% y/y »

Including $28B of net AUM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

ADBE

Adobe

$238.05

-10.84 (-4.36%)

06:11
10/16/18
10/16
06:11
10/16/18
06:11
Recommendations
Adobe analyst commentary  »

Adobe remains a top pick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

, SNY

Sanofi

$43.45

0.56 (1.31%)

06:10
10/16/18
10/16
06:10
10/16/18
06:10
Periodicals
Pharma pushes back against required listing of drug prices in TV ads, WSJ says »

The pharmaceutical…

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

SNY

Sanofi

$43.45

0.56 (1.31%)

RHHBY

Roche

$0.00

(0.00%)

AZN

AstraZeneca

$37.46

0.31 (0.83%)

PFE

Pfizer

$43.11

-0.67 (-1.53%)

LLY

Eli Lilly

$110.69

0.2 (0.18%)

MRK

Merck

$69.46

-0.31 (-0.44%)

GSK

GlaxoSmithKline

$38.87

0.56 (1.46%)

NVS

Novartis

$83.14

0.37 (0.45%)

BMY

Bristol-Myers

$57.59

0.09 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 24

    Dec

  • 11

    Jan

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

  • 28

    Apr

AMZN

Amazon.com

$1,760.99

-27.64 (-1.55%)

06:10
10/16/18
10/16
06:10
10/16/18
06:10
Periodicals
Amazon's announcement of HQ2 'imminent,' Recode reports »

Amazon's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 25

    Oct

UTHR

United Therapeutics

$123.41

0.26 (0.21%)

, MNKD

MannKind

$1.66

0.06 (3.75%)

06:10
10/16/18
10/16
06:10
10/16/18
06:10
Hot Stocks
United Therapeutics, MannKind announce closing of license agreement »

United Therapeutics…

UTHR

United Therapeutics

$123.41

0.26 (0.21%)

MNKD

MannKind

$1.66

0.06 (3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$427.40

-0.18 (-0.04%)

06:09
10/16/18
10/16
06:09
10/16/18
06:09
Earnings
BlackRock reports Q3 adjusted EPS $7.52, consensus $6.84 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

06:08
10/16/18
10/16
06:08
10/16/18
06:08
Hot Stocks
J.B. Hunt CFO says Oct peak season freight should be 'very normal', Dec 'strong' »

In its conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

LN

Line Corp.

$35.10

-0.81 (-2.26%)

06:07
10/16/18
10/16
06:07
10/16/18
06:07
Upgrade
Line Corp. rating change  »

Line Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.